Company intelligence / Profile preview
Support
- Ownership
- Private
- Development stage
- Other
Overview
Supportive Therapeutics is a Boston-based biotechnology company focused on developing innovative therapies for the supportive care of oncology patients. The company's primary mission is to address the side effects and complications associated with cancer treatments, such as chemotherapy and radiation. Its lead programs include small molecule candidates designed to improve the quality of life for patients undergoing intensive cancer therapy. By targeting unmet needs in supportive oncology, the company aims to reduce treatment-related morbidity and enhance patient adherence to primary cancer regimens.
- Therapeutic areas
- OncologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Support.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Support.